accountbeen adjusting its strategy accordingly. While the company recently completed its $3.6 billion deal for painkiller maker King Pharmaceuticals Inc., analysts have been expecting Pfizer to spin off several of its business units. Pfizer said in October it...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Pfizer Sells Capsugel Unit for $2.4 Billion
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account